Investigational Site Number :7240016

Barcelona, Barcelona [Barcelona] 08036

0 studies enrolling now · 2 studies all time

What they study most

Multiple Sclerosis, Non-relapsing Secondary Progressive Multiple Sclerosis

Studies at this site

• Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis — Running, not enrolling
• Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES) — Completed